Somatic Mutations in MAP3K5 Attenuate Its Proapoptotic Function in Melanoma through Increased Binding to Thioredoxin
Open Access
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 134 (2) , 452-460
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaNature Genetics, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencingNature Genetics, 2011
- Treatment implications of the emerging molecular classification system for melanomaThe Lancet Oncology, 2011
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaNature, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4Nature Genetics, 2009
- Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanomaNature Genetics, 2009
- Mutations of the BRAF gene in human cancerNature, 2002